Schuler U, Ehninger G
Medizinische Klinik, Universität Tübingen, Federal Republic of Germany.
Ann Hematol. 1992 Jun;64 Suppl:A152-7. doi: 10.1007/BF01715371.
After bone marrow transplantation, a number of viral infections contribute to the morbidity and mortality of the procedure. Established preventive measures to avoid primary infection and reactivation of herpes-and cytomegaloviruses are outlined. Possible future strategies against these viruses (e. g., monoclonal antibodies, transfer of T-lymphocytes) and the possible role of improved diagnostic tools are briefly discussed.
